Assessing Device Development and Regulation for Advanced Innovation
Sponsors: Datwyler, Haselmeier, Mitsubishi Gas Chemical, Nemera, ZEON

Exhibitors: Credence MedSystems, Kymanox, Noble, Owen Mumford Pharmaceutical Services, SCHERDEL Medtec

SAE Media Group’s 7th Annual Pre-Filled Syringes West Coast Conference will be back for 2023 in San Diego to bring together the device developers, innovative biotech, and big pharma.

This year’s conference will explore the exciting advances in the combination product drug delivery space and a future outlook exploring how pharma, device developers and regulators can work together to encourage innovation.

With the injectable drug delivery industry rapidly advancing year-to-year, administration using pre-filled syringes, auto-injectors, and pen-injectors are increasingly common. Innovations in device technology, such as connected devices are leading the way in device design in addition to injectable delivery devices for novel and large volume drugs. With the need for self-administration growing, there is an enhanced demand for on-body injectors and digitalised health as well as patient centricity. We are beginning to see environmental sustainability being incorporated into aspects of device lifecycle from design to manufacturing and the use of the device. This year’s conference looks to address these hot topics through case studies and industry insights.

As part of SAE’s leading injectable drug delivery conferences this is a must attend event; not only will the conference bring delegates key insights to enhance their drug device portfolio, but it will also give them the opportunity to network with key industry players. 

Benefits of Attending:

• Engage with industry representatives about the latest technologies and advances within the injectable device market and directions to take to advance your device portfolio
• Gain insight into new technologies for wearable injectors he delivery of novel and large volume drugs
• Understand the latest regulatory requirements and guidance to ensure your combination products are compliant such as meeting essential performance requirements
• Delve into aspects of primary packaging such as material components to consider during device design to ensure drug stability and safety
• Explore how digital technologies such as companion apps are being incorporated into drug delivery devices to improve user-centricity

Who should attend:

Directors, Heads of Departments and Managers for the following areas:

• Device Development
• Device Engineering
• Combination Product Development
• Drug Delivery Devices
• Primary Packaging Development
• Digital Health
• Large Volume Drug Delivery
• Novel Drug Product Formulation
• Regulatory Affairs

Early Bird Rates:

• EB1 – 28 Feb 2023 – US$400
• EB2 -31 March 2023 – US$200
• EB3 – 28 April 2023 – US$100

Additional Contact Info:

T: +44 (0)20 7827

E: Hannah.Blake@saemediagroup.com

W: http://www.prefilled-syringes-westcoast.com/PharmaJournalist-El